Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome

被引:29
作者
Xiao, Jianfeng [1 ]
Vemula, Satya R. [1 ]
Xue, Yi [1 ]
Khan, Mohammad M. [1 ]
Carlisle, Francesca A. [2 ]
Waite, Adrian J. [2 ]
Blake, Derek J. [2 ]
Dragatsis, Ioannis [3 ]
Zhao, Yu [1 ]
LeDoux, Mark S. [1 ,4 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, 847 Monroe Ave,Suite 226 Johnson Bldg, Memphis, TN 38163 USA
[2] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Gen, Cardiff CF24 4HQ, S Glam, Wales
[3] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA
[4] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA
基金
美国国家卫生研究院;
关键词
Sgce; Dystonia; Myoclonus; Sarcoglycans; Gene trap; EPSILON-SARCOGLYCAN GENE; KNOCK-IN MOUSE; PSYCHIATRIC-DISORDERS; PURKINJE-CELLS; MOTOR DEFICITS; CROSS-MAZE; MUTATIONS; MODEL; PHENOTYPES; SPECTRUM;
D O I
10.1016/j.nbd.2016.11.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Loss-of-function mutations in SGCE, which encodes epsilon-sarcoglycan (epsilon-SG), cause myoclonus-dystonia syndrome (OMIM159900, DYT11). A "major" epsilon-SG protein derived from CCDS5637.1 (NM_003919.2) and a "brain-specific" protein, that includes sequence derived from alternative exon 11b (CCDS47642.1, NM_001099400.1), are reportedly localized in post- and pre-synaptic membrane fractions, respectively. Moreover, deficiency of the "brain-specific" isoform and other isoforms derived from exon 11b may be central to the pathogenesis of DYT11. However, no animal model supports this hypothesis. Gene-trapped ES cells (CMHD-GT_148G1-3, intron 9 of NM_011360) were used to generate a novel Sgce mouse model (C57BL/6J background) with markedly reduced expression of isoforms derived from exons 3' to exon 9 of NM_011360. Among those brain regions analyzed in adult (2 month-old) wild-type (WT) mice, cerebellum showed the highest relative expression of isoforms incorporating exon 11b. Homozygotes (Sgce(Gt(148G1)Cmhd/Gt(148G1)Cmhd) or Sgce(Gt/Gt)) and paternal heterozygotes (Sgce(m+/pGt), m-maternal, p-paternal) showed 60 to 70% reductions in expression of total Sgce. Although expression of the major (NM_011360) and brain-specific (NM_001130189) isoforms was markedly reduced, expression of short isoforms was preserved and relatively small amounts of chimeric epsilon-SG/beta-galactosidase fusion protein was produced by the Sgce gene-trap locus. Immunoaffinity purification followed by mass spectrometry assessments of Sgce(m+/pGt) mouse brain using pan- or brain-specific epsilon-SG antibodies revealed significant reductions of epsilon-SG and other interacting sarcoglycans. Genome-wide gene-expression data using RNA derived from adult Sgce(m+/pGt) mouse cerebellum showed that the top up-regulated genes were involved in cell cycle, cellular development, cell death and survival, while the top down-regulated genes were associated with protein synthesis, cellular development, and cell death and survival. In comparison to WT littermates, Sgce(m+/pGt) mice exhibited "tiptoe" gait and stimulus-induced appendicular posturing between Postnatal Days 14 to 16. Abnormalities noted in older Sgce(m+/pGt) mice included reduced body weight, altered gait dynamics, and reduced open-field activity. Overt spontaneous or stimulus-sensitive myoclonus was not apparent on the C57BL/6J background or mixed C57BL/6J-BALB/c and C57BL/6J-129S2 backgrounds. Our data confirm that mouse Sgce is a maternally imprinted gene and suggests that short Sgce isoforms may compensate, in part, for deficiency of major and brain-specific Sgce isoforms. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 65
页数:14
相关论文
共 54 条
[1]   Second-generation antipsychotics - Is there evidence for sex differences in pharmacokinetic and adverse effect profiles? [J].
Aichhorn, Wolfgang ;
Whitworth, Alexandra B. ;
Weiss, Elisabeth M. ;
Marksteiner, Josef .
DRUG SAFETY, 2006, 29 (07) :587-598
[2]   Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene [J].
Asmus, F ;
Salih, F ;
Hjermind, LE ;
Ostergaard, K ;
Munz, M ;
Kühn, AA ;
Dupont, E ;
Kupsch, A ;
Gasser, T .
ANNALS OF NEUROLOGY, 2005, 58 (05) :792-797
[3]   "Jerky" Dystonia in Children: Spectrum of Phenotypes and Genetic Testing [J].
Asmus, Friedrich ;
Langseth, Annette ;
Doherty, Elaine ;
Nestor, Therese ;
Munz, Marita ;
Gasser, Thomas ;
Lynch, Tim ;
King, Mary D. .
MOVEMENT DISORDERS, 2009, 24 (05) :702-709
[4]   Screening for Partial Conjunction Hypotheses [J].
Benjamini, Yoav ;
Heller, Ruth .
BIOMETRICS, 2008, 64 (04) :1215-1222
[5]   THE FOCUSING POSITIONS OF POLYPEPTIDES IN IMMOBILIZED PH GRADIENTS CAN BE PREDICTED FROM THEIR AMINO-ACID-SEQUENCES [J].
BJELLQVIST, B ;
HUGHES, GJ ;
PASQUALI, C ;
PAQUET, N ;
RAVIER, F ;
SANCHEZ, JC ;
FRUTIGER, S ;
HOCHSTRASSER, D .
ELECTROPHORESIS, 1993, 14 (10) :1023-1031
[6]   Developmental and Benign Movement Disorders in Childhood [J].
Bonnet, Cecilia ;
Roubertie, Agathe ;
Doummar, Diane ;
Bahi-Buisson, Nadia ;
de Cock, Valerie Cochen ;
Roze, Emmanuel .
MOVEMENT DISORDERS, 2010, 25 (10) :1317-1334
[7]   Defining the Epsilon-Sarcoglycan (SGCE) Gene Phenotypic Signature in Myoclonus-Dystonia: A Reappraisal of Genetic Testing Criteria [J].
Carecchio, Miryam ;
Magliozzi, Monia ;
Copetti, Massimiliano ;
Ferraris, Alessandro ;
Bernardini, Laura ;
Bonetti, Monica ;
Defazio, Giovanni ;
Edwards, Mark J. ;
Torrente, Isabella ;
Pellegrini, Fabio ;
Comi, Cristoforo ;
Bhatia, Kailash P. ;
Valente, Enza Maria .
MOVEMENT DISORDERS, 2013, 28 (06) :787-794
[8]   Generation and characterization of Dyt1 ΔGAG knock-in mouse as a model for early-onset dystonia [J].
Dang, MT ;
Yokoi, F ;
McNaught, KSP ;
Jengelley, TA ;
Jackson, T ;
Li, JY ;
Li, YQ .
EXPERIMENTAL NEUROLOGY, 2005, 196 (02) :452-463
[9]   Beneficial Effects of Nrf2 Overexpression in a Mouse Model of Alexander Disease [J].
Daniels, Christine M. LaPash ;
Austin, Elizabeth V. ;
Rockney, Danica E. ;
Jacka, Elizabeth M. ;
Hagemann, Tracy L. ;
Johnson, Delinda A. ;
Johnson, Jeffrey A. ;
Messing, Albee .
JOURNAL OF NEUROSCIENCE, 2012, 32 (31) :10507-10515
[10]   Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes [J].
du Montcel, ST ;
Clot, F ;
Vidailhet, M ;
Roze, E ;
Damier, P ;
Jedynak, CP ;
Camuzat, A ;
Lagueny, A ;
Vercueil, L ;
Doummar, D ;
Guyant-Maréchal, L ;
Houeto, JL ;
Ponsot, G ;
Thobois, S ;
Cournelle, MA ;
Durr, A ;
Durif, F ;
Echenne, B ;
Hannequin, D ;
Tranchant, C ;
Brice, A .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (05) :394-400